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Abstract
Background: Previously we described a 184-kb ColV plasmid, pAPEC-O2-ColV, that contributed
to the ability of an E. coli to kill avian embryos, grow in human urine, and colonize the murine kidney.
Here, the roles of several genes encoded by this plasmid in virulence were assessed using
mutational and transcriptional analyses.
Methods: Genes chosen for deletion were iss, tsh, iutA, iroN, sitA, and cvaB. In addition, a 35-kb
region of the plasmid, containing iss, tsh, and the ColV and iro operons, along with a 15-kb region
containing both the aerobactin and sit operons, were deleted. Mutants were compared to the wild-
type (APEC O2) for lethality to chick embryos and growth in human urine. Expression of the
targeted genes was also assessed under these same conditions using RT-PCR
Results: No significant differences between the mutants and the wild-type in these phenotypic
traits were detected. However, genes encoding known or predicted iron transport systems were
up-regulated during growth in human urine, as compared to growth in LB broth, while iss, hlyF, and
iroN were strongly up-regulated in chick embryos.
Conclusion: While no difference was observed between the mutant strains and their wild-type
parent in the phenotypic traits assayed, we reasoned that some compensatory virulence
mechanism, insensitivity of the virulence assays, or other factor could have obscured changes in the
virulence of the mutants. Indeed we found several of these genes to be up-regulated in human urine
and/or in the chick embryo, suggesting that certain genes linked to ColV plasmids are involved in
the establishment of avian extraintestinal infection.
Background
A 184-kb ColV plasmid, known as pAPEC-O2-ColV, was
sequenced and analyzed [1]. In addition to regions
devoted to plasmid transfer, maintenance, and replica-
tion, pAPEC-O2-ColV was found to contain a 94-kb puta-
tive pathogenicity island (PAI), containing hlyF, ompT, iss,
tsh, the ColV operon, and several genes encoding known
or predicted iron transport systems. The iron-related sys-
tems included those encoding aerobactin and salmoche-
lin, and the sit  ABC transport system. Additionally,
pAPEC-O2-ColV contained a putative iron transport sys-
tem novel to APEC called eit and another putative ABC
transport system known as ets. This plasmid was transmis-
sible by conjugation from the donor, avian pathogenic
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Escherichia coli (APEC) O2, to recipient strains, and it was
found to co-transfer with a large R plasmid known as
pAPEC-O2-R [2]. When the role of APEC O2's plasmids in
virulence was investigated, it was found that acquisition
of these plasmids resulted in an enhancement in the recip-
ient's ability to kill avian embryos, grow in human urine,
and colonize the murine kidney [3]. It was thought that
the increase in virulence was likely due to acquisition of
pAPEC-O2-ColV [3].
Also, a study of the distribution of genes of pAPEC-O2-
ColV's putative PAI in APEC and avian fecal commensal E.
coli (AFEC) isolates revealed that a portion of this PAI was
highly conserved among APEC and that these conserved
genes occurred much more often in APEC than in com-
mensal strains [4,5]. This conserved portion, which
occurred in most of the APEC examined, included sit, an
iron/manganese transport system [6,7]; salmochelin and
aerobactin, both siderophore iron acquisition systems
[8,9]; ets, a putative ABC transport system [1]; hlyF, an
avian hemolysin [10]; iss, the increased serum survival
gene [11]; ompT, an outer membrane protease [12]; the
RepFIB replicon; and the 5' end of the ColV operon [1,4].
The variable portion of this PAI contained the 5' end of
the ColV operon; tsh, the temperature sensitive hemagglu-
tinin gene [13,14]; and the eit  operon [1]. The split
between conserved and variable portions occurred within
the cvaB gene of the ColV operon, with the 5' end of cvaB
and many of its upstream genes occurring significantly
more often among APEC than the 3' end of cvaB  and
many of its downstream genes [1,4]. Genes of these plas-
mid-linked PAIs occur widely among APEC isolated from
different parts of the world [5,15-20] various avian host
species [5,15,20] and different syndromes [5,21]. These
observations suggest that these plasmid-linked PAIs, espe-
cially their conserved portions, might be a defining char-
acteristic of the APEC pathotype [5] that could be
exploited in colibacillosis control. Indeed, protocols for
rapid characterization of APEC based on detection of cer-
tain virulence genes, including some from this cluster,
show promise [22,23].
While the data from these epidemiological studies are use-
ful at identifying genes of interest and have been widely
used to characterize avian E. coli [5,15,22,23], they are no
substitute for an in-depth study of the contributions to
virulence of individual genes. Such studies typically
require comparisons of wild-type and mutant strains, dif-
fering in a single trait of interest, for their abilities to cause
disease in animal models [24]. Here, we sought to deter-
mine the contributions of certain genes of pAPEC-O2-
ColV's PAI to E. coli's ability to kill embryos and grow in
human urine using mutational analysis. When differences
in virulence between the mutants and the wild-type were
not detected, follow-up studies to determine if these same
genes are differentially expressed in APEC O2 during
infection were undertaken.
Results and Discussion
Large conjugative ColV plasmids and the genes they carry
are found in a much higher proportion of E. coli incrimi-
nated in cases of avian colibacillosis than in E. coli isolated
from the feces of apparently healthy birds [5,25]. In addi-
tion, it has been shown that ColV plasmids may mediate
avian E. coli virulence and are often implicated in cases of
human extraintestinal disease [3,26-28]. In a previous
study we found that transfer of a large ColV plasmid,
pAPEC-O2-ColV (along with a co-transferring R plasmid)
conferred upon a recipient strain enhanced abilities to kill
chick embryos, grow in human urine, and cause urinary
tract infection (UTI) in mice [3]. In the present study, we
sought to determine what regions of this ColV plasmid
contributed to these traits.
To do this, we mutated several genes localized to pAPEC-
O2-ColV. The genes chosen for mutagenesis, iss, tsh, cvaB,
iutA, iroN, and sitA, have been found to be epidemiologi-
cally associated with APEC [1,5]. In addition tsh and iroN,
have been shown to contribute to the virulence of APEC
[28,29], while virulence of E. coli K-12 was shown to be
enhanced after the acquisition of an iss encoding plasmid
[11]. The expected mutations were verified by PCR proto-
cols [30] targeting the deleted gene and the new kanamy-
cin resistance (kanR) cassette junction fragment. To ensure
that the mutants were truly isogenic, we examined the
genotype of the mutant strains for over 40 other virulence
associated genes and allelic variants using published pro-
tocols [5,12,23]. In no instance did we find a loss of a gene
other than the one which was targeted. This observation
suggests that the method of mutagenesis used in this study
may have a higher fidelity than does suicide vector driven
allelic exchange which has been found to produce second-
ary mutations at a high rate in extraintestinal pathogenic
E. coli [31].
After confirming that our mutants were isogenic, their rel-
ative virulence, as compared to the wild type, was com-
pared in two models, including those based on lethality to
chick embryos and ability to grow in human urine. None
of the mutants showed any attenuation in virulence as
compared to the wild-type parent (Table 1), and none
deviated from the wild-type pattern of growth in urine
(Figure 1). Reasoning that the virulence of APEC is multi-
factorial [5,32] and that the effects of single gene knock-
outs might be obscured by some compensatory mecha-
nism, we subsequently deleted two large regions of
pAPEC-O2-ColV to create deletions of Vir1 and Vir2.
Region Vir1 is about 33 kb in length and contains the iss
and tsh  genes along with ColV and iro  operons, while
region Vir2 is around 15 kb in length and contains the sitBMC Microbiology 2008, 8:24 http://www.biomedcentral.com/1471-2180/8/24
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and aerobactin operons (Figure 2). Deletion of these two
regions also caused no attenuation of APEC O2's viru-
lence for chick embryos (Table 1).
In view of these results, we considered the possibility that
chromosomal genes found in APEC O2 may compensate
for the function(s) of the lost plasmid genes. For example,
many of the genes targeted for deletion in APEC O2 are
associated with iron acquisition or complement resist-
ance. Since APEC O2 is known to contain at least two
other chromosomal operons (yersinabactin and entero-
bactin) involved in the acquisition of iron [1], overexpres-
sion of chromosomal iron acquisition loci might
compensate for the loss of certain plasmid-linked iron
acquisition operons. In addition, others have shown that
transfer of a ColV plasmid into a K-12 recipient was
accompanied by a concomitant increase in the K-12
strain's ability to resist the bactericidal effects of serum
complement [33]. However, other studies have demon-
strated that when a native host was cured of the ColV plas-
mid, its ability to survive in serum was not affected [28],
suggesting that chromosomal loci may compensate for
the lost plasmid genes which conferred complement
resistance. Similarly, in our work we did not find any of
the mutant derivatives of APEC O2 to be attenuated in
their ability to resist complement or to grow under low
iron conditions (data not shown).
To further investigate whether chromosomal genes found
in APEC O2 were compensating for the deleted plasmid
genes, we transferred the mutated pAPEC-O2-ColV deriv-
atives generated above into the AFEC strain NC via conju-
gation. NC was previously used as a recipient for pAPEC-
O2-ColV and was found to have enhanced abilities to kill
chick embryos and grow in human urine upon receipt of
the plasmids of APEC O2 [3]. The virulence of NC deriva-
tives containing pAPEC-O2-ColV was then compared to
that of NC with an intact version of pAPEC-O2-ColV (NC/
pAPEC-O2). Again, no differences were found. Knowing
that others have found that some of these same genes and
regions, such as tsh [28] and the iro operon [29,34], con-
Genetic map of Vir1 and Vir2 regions of pAPEC-O2-ColV, drawn to scale with ruler in base pairs Figure 2
Genetic map of Vir1 and Vir2 regions of pAPEC-O2-ColV, drawn to scale with ruler in base pairs.
Growth in urine of APEC O2 (the source of the pAPEC-O2- ColV) and its mutant derivatives Figure 1
Growth in urine of APEC O2 (the source of the pAPEC-O2-
ColV) and its mutant derivatives. Growth curves were deter-
mined by measuring viable counts (CFU ml1) and reflect an 
average of two trials for each strain.
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tribute to the virulence of other APEC, we then reasoned
that our virulence assays might be too insensitive to detect
subtle changes in virulence caused by the mutations.
Indeed, bacterial virulence, as measured with the embryo
lethality assay, has been shown to have only a moderate
correlation to results of assays done in three-week old
chickens [35]. In addition, we and others [36] have not
observed a correlation between the infectious dose of a
strain and its lethality to chick embryos which would per-
mit comparisons of virulence based on LD50 determina-
tions.
Therefore, in an effort to increase the sensitivity of our
chick embryo model, we infected 16 day-old chick
embryos (the age at which chick embryos are most resist-
ant to E. coli infection [36]) via the chorioallantoic route
with an equivalent mixture of wildtype and mutant strains
(~500 CFUs of each). Three days after infection the surviv-
ing embryos (generally > 80% of those infected) were
killed by chilling at -20 C for two hours, after which
brains, hearts, and livers were collected sterilely. Organ
homogenates were cultured quantitatively on agar with or
without antibiotics to determine the relative proportions
of the strains. The results of these mixed infection experi-
ments partially mimicked our previous embryo lethality
data [3]. Strain NC/pAPEC-O2 generally outcompeted
strain NC, and no marked differences in organ coloniza-
tion was seen with any of the mutant strains in relation to
the APEC O2 (data not shown). However, we were able to
recover E. coli from the internal of organs of only a very
small (< 15%) proportion of the embryos. This is not
entirely surprising as the systemic spread of E. coli is not
thought to be required for embryo death [36], however it
would indicate that mixed infections in 16 day-old chick
embryos may have marginal utility in assessing E. coli vir-
ulence.
Subsequently, we opted to use qRT-PCR in an effort to
better understand the nature of pAPEC-O2-ColV's role in
APEC O2's growth in human urine and infection of the
chick embryo. Here, the genes that had been targeted for
mutation plus two additional genes, hlyF, encoding an
avian hemolysin [10] and etsC, a putative ABC transport
efflux gene [1], were studied. As compared to exponential
growth in LB broth, several genes were up-regulated when
grown in human urine or during infection of the chick
embryo. In human urine, genes which were up-regulated
included sitA, iutA, iroN, cvaC, and tsh, although sitA and
tsh were not significantly up-regulated (Fig. 3). This was
not surprising, as several of these genes have been shown
to play a role in iron acquisition [6,8,9], and urine is con-
sidered to be an iron-depleted environment [24]. In the
chick embryo, different patterns of up-regulation were
observed. In general, pAPEC-O2-ColV's iron-related genes
were not up-regulated in the embryo, suggesting that the
RT-PCR results comparing expression of pAPEC-O2-ColV  genes during differential growth conditions Figure 3
RT-PCR results comparing expression of pAPEC-O2-ColV 
genes during differential growth conditions. Each bar indi-
cates standard deviation for conditions. Each trial included 
three replicates, and three biological replicates were per-
formed for each condition. An asterisk above a bar indicates 
that the difference in expression between growth in LB and 
in urine or in chick embryos was significant (p-value < 0.05).
Table 1: Embryo Lethality of APEC O2 along with its Mutant Derivatives
Strain Embryos Inoculated Deaths Embryo Lethality % Z valueA p-value
NC 41 1 2.4 6.60** < 0.01A
APEC O2 41 30 73.2 - -
APEC 02∆iss 41 29 70.7 0.25 0.81
APEC 02∆iutA 41 28 68.3 0.49 0.63
APEC 02∆tsh 41 32 78.0 0.51 0.61
APEC 02∆iroN 41 30 73.2 0.00 1.00
APEC 02∆cvaB 41 29 70.7 0.25 0.81
APEC 02∆sitA 41 29 70.7 0.25 0.81
APEC 02∆vir1 41 28 68.3 0.49 0.63
APEC 02∆vir2 41 29 70.7 0.25 0.81
A As compared to APEC O2.** p < 0.001, no other strains had a significantly different lethality rate than APEC O2BMC Microbiology 2008, 8:24 http://www.biomedcentral.com/1471-2180/8/24
Page 5 of 8
(page number not for citation purposes)
embryo may be a relatively iron-rich environment.
Indeed, it has been demonstrated that the percentage of
iron in the chick embryo liver is much higher at twelve
days of incubation than at hatching [37]. Interestingly, iss
and  hlyF  were strongly up-regulated (both at approxi-
mately 29-fold). iss  has been shown to play a role in
serum  resistance and increased lethality towards day-old
chicks [38], while hlyF has been shown to exhibit hemo-
lysin activity [10]. Such results suggest that serum resist-
ance and hemolysin production might be important to
APEC O2's infection of chick embryos. Also, iroN was up-
regulated approximately 15-fold. iroN  has previously
been found to play a dual role in E. coli's virulence, serving
both as a siderophore receptor and as a virulence factor
during urinary tract infection [34]. So too, the results here
suggest a possible dual role for iroN during avian systemic
infection.
The results of this expression analysis are intriguing and
suggest that genes localized to ColV plasmids, such as
pAPEC-O2-ColV, are involved in the pathogenesis of col-
ibacillosis. The lack of confirmatory results from the
mutational analyses illustrates the complexities of such
studies, especially where multiple alternative mechanisms
may compensate for the deleted genes/operons.
Taken altogether, the results presented here suggest sev-
eral plausible reasons for an inability to detect significant
attenuation in the mutants examined in this study. One
possibility is that the embryo lethality assay lacks the sen-
sitivity to detect changes owed to the mutated genes. This
is a distinct possibility, as acquisition of pAPEC-O2-ColV
by an avirulent recipient confers the ability to kill chick
embryos [3] while none of the isogenic mutants created in
this study and involving genes and/or regions of pAPEC-
O2-ColV were attenuated in the chick embryo model of
infection. A second possibility is that none of the deleted
genes in this study actually contribute to the abilities of
APEC O2 to kill chick embryos or grow in human urine,
although this seems unlikely based on the literature,
which suggests that several of these genes including tsh
and  iroN  [28,29,39], do contribute to the virulence of
ExPEC. In addition an association of iss with the virulence
of APEC in a respiratory model of infection has been pos-
tulated [40], however a direct role for iss in virulence was
not demonstrated. In accordance with previous findings,
we found that several of these genes were strongly up-reg-
ulated during growth of APEC O2 in these models, sug-
gesting that these genes play at least some role in urine
growth and infection. To better pinpoint the contribu-
tions of these targeted genes and ColV plasmids to APEC
virulence, more sensitive virulence assays and use of func-
tional genomics and proteomics approaches examining
the total APEC genome will be needed.
Conclusion
The differences seen in the results of the mutational and
transcriptional analyses in this study underscore the need
to use multiple approaches in ascertaining genes' contri-
butions to disease.
While the data presented here suggests roles for iss, hlyF,
and iroN during E. coli-caused septicemia, a more compre-
hensive analysis of these plasmids is necessary to better
understand their nature, and such analysis must also
include genes of unknown function found on pAPEC-O2-
ColV and other similar plasmids.
Methods
Media and bacterial strains
All bacterial strains were stored in Brain Heart Infusion
Broth (Difco Laboratories, Detroit, MI) with 20% glycerol
at -80 C prior to use [41]. Strains used in this study
included NC, APEC O2, and its mutant derivatives. Their
relevant characteristics are shown in Table 2.
Table 2: Phenotypic Characteristics of Strains/Plasmids Used
Strain or Plasmid Relevant Characteristicsa Reference and/or Source
APEC O2 Virulent to chick embryos; contains pAPEC-O2-ColV and pAPEC-O2-R Diseased Chicken [1–3]
pAPEC-O2-ColV ColV plasmid of APEC O2; contains iss, tsh, and traT genes, along with the aerobactin, ColV, 
sit and iro operons
[1,3]
pAPEC-O2-R R plasmid of APEC O2; encodes resistance to multiple antimicrobial agents [2,3]
NC Relatively avirulent to chick embryos and lacks iss, tsh, and the aerobactin, ColV, and iro 
operons
Healthy Chicken [3]
NC/pAPEC-O2 Transconjugant derivative of NC containing pAPEC-O2-ColV and pAPEC-O2-R; has 
enhanced abilities to kill chick embryos and grow in human urine relative to strain NC
[3]
pKD46 ampR ; temperature sensitive plasmid which expresses the λ Red recombinase proteins when 
induced by arabinose
[30]
pSKY5000 camR derivative of pKD46 [42]
a Abbreviations: Amp, ampicillin, Cam, chloramphenicol; ColV, colicin V; r, resistantBMC Microbiology 2008, 8:24 http://www.biomedcentral.com/1471-2180/8/24
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Mutagenesis
Deletions of targeted genes were generated in strain APEC
O2 essentially as described by Datsenko and Wanner [30],
except that red-mediated recombination proteins were
expressed by pSKY5000 rather than pKD46. pSKY5000 is
a chloramphenicol resistant (camR) derivative of pKD46
[42]. This method relies on the overproduction of λ-
derived recombination proteins encoded by the tempera-
ture-sensitive plasmid pSKY5000 and PCR amplification
of a kanR cassette in pKD4 flanked by 5' and 3' sequences
of the gene or region targeted for deletion. Cells were elec-
trotransformed, and kanamycin (50 ug/ml) resistant
derivatives were identified. After electroporation and kan
selection, the expected deletions were verified by PCR pro-
tocols targeting the deleted gene and the new kanR junc-
tion fragment [30]. Primers used for mutagenesis are
listed in Table 3, and were synthesized at Integrated DNA
Technologies (IDT; Coralville, IA).
Embryo lethality assay
APEC O2 and its mutant derivatives were assessed for
lethality in chicken embryos by inoculation of overnight
washed bacterial cultures (~500 colony forming units
(CFU)) into the allantoic cavity of 12-day old embryo-
nated, specific-pathogen-free eggs [35]. Phosphate buff-
ered saline (PBS) inoculated and uninoculated embryos
were used as controls. Embryo deaths were recorded for
four days. Differences in embryo lethality between the
strains were evaluated for statistical significance using a z-
test for the equality of two binomial proportions. P-values
of less than 0.05 were considered statistically significant
[43].
Growth in human urine
APEC O2 and its mutant derivatives were compared by
their ability to grow in human urine. The assay was per-
formed as described elsewhere [3]. Only urine from
healthy, antibiotic-free volunteers, who reported never
having experienced a UTI, was used for study. Prior to the
study, urine from five volunteers was collected, individu-
ally filter sterilized with 0.2 um filters, pooled, and stored
at -20 C. On the day before the assay was run, the strains
to be tested were grown overnight in 2 ml of Luria Bertani
(LB) broth. The next day the cell density was estimated by
spectrophotometry, and cultures were diluted in PBS prior
to inoculation (100 µl of inoculum into 4.9 ml of urine)
to achieve an approximate starting concentration of 102 to
103 CFUs per ml, which was confirmed by viable counts.
This concentration of bacteria was chosen as a starting
point since it represents the lower end of what is consid-
ered a significant indicator of UTI in symptomatic young
women [44]. Mixtures were incubated at 37 C with shak-
ing, and aliquots of these urine cultures were removed at
set time intervals for use in determining viable counts.
RNA Isolation
Chick embryos were inoculated via the allantoic cavity
with APEC O2. Two days later, 12 viable infected embryos
were removed from their eggs, and the livers were excised
and pooled together in 20 volumes of RNALater
(Ambion/Applied Biosystems, Austin, TX). RNA was
extracted from these pooled liver samples using Tri Rea-
gent (Ambion), treated with Turbo DNAse (Ambion), fol-
lowed by phenol/chloroform extraction, and
resuspension in distilled water. For in vitro isolation, a sin-
gle colony APEC O2 was inoculated into 3 ml LB Broth or
urine and grown at 37° with shaking until the cells were
in early- to mid-exponential growth phase (A600 of
approximately 0.3). Cells were than pelleted by centrifu-
gation, resuspended immediately in RNALater, and the
RNA isolated and purified as described above.
Table 3: Primers used in Mutagenesis*
Name Primer Seq. (5'-3') Target(s)*
for-mut-iutA aataatgatgataagcaaaaagtatacgctttgggctctctgtgtaggctggagctgctt iutA
rev-mut-iutA atatcagcgtacctttgttgtaaaggaataccggtcagaacatatgaatatcctccttag iutA, Vir2
for-mut-tsh atactttatgtgcaggcataacggtgctctccctgaattttgtgtaggctggagctgctt tsh, Vir1
rev-mut-tsh ttcttctactgtaccgtaatcagataatcgcagcaaagggcatatgaatatcctccttag tsh
for-mut-cvaB cataagatatatcagccgggaggaaatgagccgatatttttgtgtaggctggagctgctt cvaB
rev-mut-cvaB tcatacgcttgtaattcctctatggtttaaatagaaataacatatgaatatcctccttag cvaB
for-mut-sitA gattgcatcattatttctccctttttccggctttaattcctgtgtaggctggagctgctt sitA
rev-mut-sitA tgctcactataggtactaaattatgcactcaataaaaaaacatatgaatatcctccttag sitA
for-mut-iss tattcatttcccatgattctgagtacctaccaagtctgagtgtgtaggctggagctgctt iss
rev-mut-iss aaaaacaactgtagggagcccagaagtatattaatgaacacatatgaatatcctccttag iss
rev-mut-iroN tattagggaataggtatgagaattaacaaaatcctctggtcatatgaatatcctccttag iroN
for-mut-iroN acgatcagaatgatgcggtaactccggcatagtaagcccgtgtgtaggctggagctgctt iroN
for-mut-Vir2 tgctcactataggtactaaattatgcactcaataaaaaaatgtgtaggctggagctgctt Vir2
rev-mut-Vir1 tattcatttcccatgattctgagtacctaccaagtctgagcatatgaatatcctccttag Vir1
* Primers were created using information from GenBank Accession number NC007675.BMC Microbiology 2008, 8:24 http://www.biomedcentral.com/1471-2180/8/24
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RT-PCR
Primers for qRT-PCR were designed using software from
IDT (Coralville, IA) and also synthesized by IDT. One-
step real-time RT-PCR was carried out using an iCycler
real-time thermal cycler (Bio-Rad Life Sciences, Hercules,
CA) and the iScript One-Step RT-PCR Kit with SYBR Green
(Bio-Rad Life Sciences) according to manufacturer's rec-
ommendations. Differential gene expression during infec-
tion for reference (Glyceraldehyde 3-phosphate
dehydrogenase A gene, i.e.,gapA) and target genes (Table
4) was calculated using the comparative RT-PCR methods
described by Pfaffl [45], where differences in cycle thresh-
old ratios are assessed while accounting for reaction effi-
ciencies. Efficiency and melting curves were generated for
each gene assayed. A negative control containing all rea-
gents except reverse transcriptase was included to rule out
DNA contamination. Results for each target gene are pre-
sented as ratio of expression of that gene in treated cells
versus the untreated cells, corrected using the reference
gene gapA and reaction efficiencies for each gene. Reac-
tions were performed in triplicate, and at least two inde-
pendent trials were performed for each gene and
condition assessed. Standard deviations were calculated
for the averages of all of the trials for each gene and con-
dition, and the results plotted. Double-sided p-values
were calculated for the relative means using the t-test. P-
values of less than 0.05 were considered statistically sig-
nificant [43].
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